STUDY QUESTION: Do long non-coding RNA (lncRNA) and messenger RNA (mRNA) profiles in follicular fluid from mature and immature ovarian follicles differ between healthy women and women with polycystic ovary syndrome (PCOS)?
active in follicular development, and monosaccharide biosynthesis might provide possible pathway markers to distinguish between normal and PCOS follicles. We constructed gene co-expression networks that identified many co-regulatory relationships among follicular fluid lncRNAs, mRNAs, and PCOS phenotypes. Weighted Gene Co-expression Network Analysis (WGCNA) revealed lncRNAs and mRNAs that were core and others associated with the PCOS phenotype.
Introduction
Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism, chronic anovulation, and polycystic ovaries, and it affects between 5% and 20% of women of reproductive age (Azziz et al., 2016) . Accumulating evidence indicates that an intrinsic abnormality of early follicle development (Stubbs et al., 2007) and arrested follicular growth (Ambekar et al., 2015) are critical factors in the pathogenesis of PCOS.
Although the initial stages of follicle development proceed slowly, small antral follicles grow rapidly due to granulosa cell proliferation, expansion of the follicular basal lamina, and the formation of follicular fluid (Fortune, 1994) . Follicular fluid is a complex biologic fluid that plays a critical role in oocyte growth, follicular maturation, and germ cell-somatic cell interactions (Zamah et al., 2015) . Recent studies indicate that follicular fluid contains proteins, metabolites, various ionic compounds, and microRNAs (miRNAs) that are widely involved in follicle development (Sang et al., 2013) . Long non-coding RNAs (lncRNAs) are a type of non-coding RNAs with a length exceeding 200 nucleotides. These lncRNAs contribute to transcriptional and post-transcriptional functions, and can be broadly classified as signaling molecules, decoy molecules, guide molecules or scaffold molecules (Wang and Chang, 2011; Lorenzen and Thum, 2016) . Unlike miRNAs (which have been extensively studied), lncRNAs present in follicular fluid have never been sequenced. We therefore hypothesized that human follicular fluid contains lncRNAs that are involved in the development of both normal ovarian follicles and follicles in women with PCOS. Thus, the present study was aimed at describing the features of lncRNAs and messenger RNAs (mRNAs) in follicular fluid from mature and immature follicles of healthy women and PCOS patients using RNA sequencing and linking the characteristic lncRNAs and mRNAs to PCOS phenotypes.
Materials and Methods

Ethical statement
This study was conducted in accordance with ethical standards and the Helsinki Declaration of 1975.
Patients and follicular fluid samples
This study was approved by the Institutional Review Board at China Medical University. A total of 18 subjects (8 controls and 10 PCOS patients) were recruited to participate, and recruitment took place from May 2016 to September 2016. Follicular fluid donors underwent their first round of in-vitro fertilization treatment, and all of the patients gave informed consent. Control and PCOS patient ovaries were stimulated with recombinant follicle-stimulating hormone (FSH) (Merck-Serono, Switzerland) after pretreatment with gonadotropin-releasing hormone agonist (Diphereline, Ipsen Pharma Biotech, France). FSH stimulation was started when down-regulation was confirmed by vaginal ultrasonography and by measurements of serum estradiol and luteinizing hormone. Ultrasonography was used to evaluate follicular development from Day 5 of stimulation until the day of follicular maturation. When at least one follicle grew to 18 mm in diameter, 250 μg of recombinant hCG (Ovidrel, Merck-Serono, Switzerland) was administered, and oocyte retrieval was performed 34-36 h later. Follicle size was determined based upon the average follicular diameter, and follicular fluid samples from mature follicles (17-22 mm) and matched-immature follicles (8-13 mm) were stored separately. The follicular fluid samples were centrifuged at 12,000g for 10 min to remove blood, and the remaining fluid was used in subsequent studies. PCOS was diagnosed according to the 2003 Rotterdam criteria (Rotterdam, 2004 . The subjects' characteristics are provided in Table I .
RNA isolation, quantification and qualification
Total RNA was isolated using TRIzol (Invitrogen, CA, USA), and RNA degradation was detected by 1% agarose gels. RNA purity and integrity were assessed using a NanoPhotometer ® spectrophotometer (IMPLEN, CA, USA) and RNA Nano 6000 Assay Kit (Agilent Technologies, CA, USA), respectively. RNA concentration was measured using the Qubit ® RNA Assay Kit (Life Technologies, CA, USA).
Library preparation for lncRNA and mRNA sequencing
Three micrograms of RNA was used as input material. Ribosomal RNA was completely removed using the Epicentre Ribo-zero™ rRNA Removal Kit (Epicentre, Madison, USA), and then sequencing libraries were generated with the NEBNext ® Ultra™ Directional RNA Library Prep Kit for Illumina ® (NEB, Ispawich, USA). First-strand cDNA was synthesized using M-MuLV Reverse Transcriptase and random hexamer primers, and second-strand cDNA was synthesized using RNase H and DNA polymerase I. After adenylation of the 3′ ends of DNA fragments, NEBNext Adaptors were ligated to prepare for hybridization. The library fragments were purified for selecting cDNA fragments (150-200 bp in length). Finally, the products were purified with a AMPure XP system (Beckman Coulter, Beverly, USA). The libraries were sequenced on an Illumina Hiseq 2500 platform, and 100-bp paired-end reads were generated. Sequencing data were deposited with the NCBI Sequence Read Archive (SRA) under accession number PRJNA415272.
Data analysis
Raw reads were first processed with Perl scripts, and the clean reads were obtained after removing the contained adapter or ploy-N reads and low-quality reads. All of the analyses were based on the clean data. Reference genome and annotation files were downloaded directly from the publicly available website (ftp://ftp.ensembl.org/pub/release-88/). An index of the reference genome was built using Bowtie v2.0.6, and TopHat v2.0.9 was used for aligning the paired-end clean reads to the reference genome. The mapped reads were assembled using Scripture (beta2) (Guttman et al., 2010) and Cufflinks (v2.1.1) (Trapnell et al., 2009 ) in a reference-based approach.
Principal component analysis
Principal component analysis (PCA) was performed to detect and visualize the variation of lncRNA and mRNA expression data in follicular fluid from mature and immature follicles within and between woman by R packages:
ggplot2, pca3d and rgl. It is used to explain the variance-covariance structure of a set of variables through linear combinations. We plot 2D and 3D graphs by two and three main principal components. The results show that each group has high similarity and low variation among its samples (Supplementary Fig. S1A and B).
Coding potential analysis
CNCI, CPC, PFAM and phyloCSF were used to assess the coding potential of transcripts. CNCI, by adjoining nucleotide triplets, can effectively distinguish coding and non-coding transcripts (Sun et al., 2013) , whereas CPC mainly assesses the quality and extent of the open reading frame in a transcript and searches sequences within a known protein sequence database to clarify the coding and non-coding transcripts (Kong et al., 2007) . We translated each transcript for three possible frames and then used PfamScan (v1.3) to identify the occurrence of documented protein family domains (release 27; both Pfam A and Pfam B were used) (Punta et al., 2012) . The phyloCSF method was applied to assess the evolutionary signature characteristics of alignments with conserved coding regions so as to distinguish coding and non-coding transcripts (Lin et al., 2011) . A flowchart depicting screening strategy was designed and presented in Fig. 1A -C. For these novel transcripts, if at least one was predicted to possess coding potential, it was added to our candidate set of TUCPs (transcripts of uncertain coding potential). Those transcripts without coding potential were added to our candidate set of novel lncRNAs. Step 1
Step 2
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Conservation analysis
Phast (v1.3) contains many of the statistical programs that are often used in phylogenetic analysis, and we used phastCons to identify conserved elements as follows. First, phyloFit was used to compute phylogenetic models, and then we set the model and HMM transition parameters for phastCons to compute the conservation scores of lncRNAs and coding genes.
Quantification of gene expression levels and differential expression analysis
The Cuffdiff (v2.1.1) algorithm was used to quantify fragments per kilobase of exon per million fragments mapped (FPKMs) for lncRNAs and coding genes (Trapnell et al., 2010) . In each gene group, FPKMs were obtained by summing the FPKMs of transcripts, and calculated based on the fragments length and reads count mapped to a particular fragment. Cuffdiff is suitable for determining the differential gene expression in digital transcripts, which uses a model based on the negative binomial distribution (Trapnell et al., 2010) . Transcripts with a P-adjust (q value) <0.05 were assigned as differentially expressed. The inf data were ignored.
STRING, Gene Ontology and Kyoto
Encyclopedia of Genes and Genomes enrichment analysis STRING (https://www.string-db.org) was used to find interactions, and the minimal required interaction score was set at medium confidence (greater or equal to 0.400) (Szklarczyk et al., 2017) . Gene Ontology (GO) analysis of the differentially expressed genes or lncRNAs and transcripts of uncertain coding potential (TUCP) target genes was assessed using the GOseq R package. GO terms with a corrected P < 0.05 were considered to be significantly enriched. We used KOBAS 3.0 (http://kobas.cbi.pku. edu.cn) software to test the statistical enrichment of differentially expressed genes or lncRNAs and TUCP target genes in Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways (Xie et al., 2011) .
Gene Set Enrichment Analysis
Gene Set Enrichment Analysis (GSEA) was performed on the identified clusters to reveal mRNA functions in follicular fluid from mature and immature follicles in normal ovaries and ovaries from PCOS patients. The GSEA was performed using GSEA software version 3.0, which uses pre-defined gene sets from the Molecular Signatures Database version 6.0. GSEA-GO analysis was performed using GSEA against c5.all.v6.1. symbol.gmt. The normalized enrichment score is the primary statistic for examining gene set enrichment results. Using a permutation test 1000 times, the cut-off of the significance level P-value was selected as 0.05 for the significant GO terms in the comparison of follicular fluid from mature and immature follicles in normal ovaries and ovaries from PCOS patients (Subramanian et al., 2005) . After we classified significantly enriched gene sets of GO into several clusters, we performed leading-edge analysis with each cluster (cut-off nominal, P < 1%) in GSEA. Leading Edge Analysis helped us visualize the overlap between the selected leading-edge subsets. All of these overlapping genes in each cluster were retrieved for data visualization by using the RCircos package.
Weighted Gene Co-expression Network Analysis
Weighted Gene Co-expression Network Analysis (WGCNA) was performed to identify candidate causal mRNAs and lncRNAs underlying PCOS phenotypes, and potential co-regulatory relationships among lncRNAs, mRNAs and PCOS phenotypes in follicular fluid. As described by Langfelder and Horvath (2008) , WGCNA was used for finding clusters of highly correlated mRNAs, lncRNAs, and mRNAs/lncRNAs; for summarizing such clusters using the module eigengene or intramodular hub mRNAs and lncRNAs; for relating modules to one another and to external sample traits (using eigengene network methodology); and for calculating module Gene Significance (GS) and Module Membership (MM) measures to identify significant modules. The WGCNA R package was downloaded from Bioconductor (https://bioconductor.org/) and installed separately in R 3.4.1 (https://www.r-project.org/). The network visualization was performed with Cytoscape 3.4.0 software (http://www.cytoscape.org/) (Shannon et al., 2003) .
Statistical analyses
Descriptive results of study participants are expressed as means ± SD or median (interquartile range). Comparisons between PCOS patients and controls were performed using independent-sample t test or MannWhitney U-test (Table I) . P < 0.05 was considered to indicate statistically significant differences.
Results
RNA sequencing identifies the features of lncRNAs, TUCPs and mRNAs in human follicular fluid
We analyzed RNA sequencing data from 36 human follicular fluid samples, and obtained 1563,368 assembled transcripts. After screening using rigorous criteria ( Fig. 1A and B), four analytical tools (CPC, PFAM, phyloCSF, and CNCI) were used to remove potential coding transcripts; and a total of 1583 novel lncRNAs were identified (Fig. 1C) . These novel lncRNAs consisted of 95.2% long intergenic non-coding RNAs (lincRNAs) and 4.8% antisense lncRNAs; virtually no intronic lncRNAs were detected (Fig. 1D) . Also, some studies have suggested that lncRNAs are shorter in length and less conserved than coding transcripts (Trapnell et al., 2012) ; and our data agree, showing that in comparison to mRNAs, the human follicular fluid lncRNAs were less conserved ( Fig. 1E and F), shorter in total length (Supplementary Fig. S1C ) and in the length of the open reading frame ( Supplementary  Fig. S1D ), and possessed fewer exons ( Supplementary Fig. S1E ). TUCP levels were significantly higher than levels of lncRNAs or mRNAs in the human follicular fluid samples ( Fig. 1G-I ), but there was no significant difference in transcript levels in follicular fluids from mature or immature follicles in either normal or PCOS ovaries ( Fig. 1J-L ).
Differences in gene expression patterns of lncRNAs, TUCPs and mRNAs in human follicular fluid
To further confirm the potential molecular diversity of mature and immature follicles in normal and PCOS ovaries ( Fig. 2A) , the expression patterns of lncRNAs, TUCPs and mRNAs were respectively analyzed. The results indicated four main findings. First, four lncRNAs, two TUCPs, and 19 mRNAs differed in their expression between follicular fluids from normal mature and immature follicles; and 2 of the lncRNAs* and both TUCPs* were identified as novel transcripts (Fig. 2B and Supplementary  Table S1 ). Second, 44 lncRNAs, five TUCPs, and 63 mRNAs differed in their expression between follicular fluids from PCOS and normal mature BMP5  SGPP2  CACNG8  CTAGE6  RP1L1  FAM127C  POU3F4  EMILIN2  GPC4  L1TD1  ZBED4  TRABD2B  DISP2  NYNRIN  SPON1  OR8G5  CCR4  SRD5A1  SERTM1  ZNF385D  MAS1  ERCC6L2  FKBP1C  KLHL11  KLHL30  DKK1  LMBRD2  LCE2C  KRTAP4-6  OCSTAMP  PRR32  OR9K2  LRRN4  OR10Q1  OR52M1  OR6C76  HOXB2  DMRTA1  KCNG2  OR5A1  OR5K3  OR6B3  UTF1  PRR21  VAX2  OR7E24  OR1S1  N4BP3  IFNW1  HRCT1  ADRA1D  CCDC184  LHX5  C1QL2  RPL10L   OR8K1  PLGRKT  OR10K1  SMKR1  OR4D10  SPRR2A  PI HSD11B2  PLGRKT  PLAC1  OR10H3  HIST1H4A  NIPSNAP3A  HIST1H2AG  C17orf67  ENAM  OR4A5  OR1G1  LAMP1  OR1L3  L1TD1  VWC2  IFNW1  TCN1  DISP2  SNX4  SLC25A4  TMEM43  TAF3  OR1D2  OTUD3  EFNB3  CD207  OR9K2  ZNF8  MOCOS  TCF24  SLX4IP  CACNG3  EMILIN2  OR6N1  NYNRIN  OR1S1  PCBD1  KLHL11  SMDT1  UPK3BL  CYS1  NUDT11  ZBED4  OR4A15  MRPS26  C17orf105  CREG2  DKK1  GPC4  SPON1  OR6K2  HRCT1  OR6C76  EID2  N4BP3  LMBRD2  BMP5  OR1Q1  COL4A4  SERTM1  FAM127C  CCR4  ANKRD33B  ERCC6L2  OR4B1  CACNG8  SGPP2  ADRA1D  MUL1  CCDC184  RASD2  TRABD2B  HIST1H2AH KRTAP1-3 KRTAP4-6 C1orf233 AL357140. NENF  KIR3DX1  TM9SF2  VNN1  NKAPL  OSTF1  RAB3B  SPRR2A  OR6P1  TAS2R16  OR2B11  OR8K1  KRTAP4- follicles; 10 of these lncRNAs* and all five TUCPs* were identified as novel transcripts (Fig. 2C and Supplementary Table SII) . Third, 48 lncRNAs, 15 TUCPs, and 78 mRNAs differed in their expression between follicular fluids from mature and immature follicles of PCOS patients; 20 of these lncRNAs* and all 15 TUCPs* were identified as novel transcripts ( Fig. 2D and Supplementary Table SIII) . Finally, 13 lncRNAs, six TUCPs and 26 mRNAs differed in their expression between follicular fluids from PCOS and normal immature follicles; nine of these lncRNAs* and all six TUCPs* were identified as novel transcripts (Fig. 2E and Supplementary Table SIV) . Notably, differentially expressed TIMM17A, OR4F29, NPR1 and KRTAP4-6 were observed between follicular fluids of PCOS and normal follicles, regardless of whether they were mature or immature ( Supplementary Fig. S2A ). KRTAP4-6 also differed in its expression between follicular fluids from mature and immature follicles, regardless of whether follicles were normal or from women with PCOS ( Supplementary Fig. S2B ).
Systematic functional analysis of differentially expressed lncRNAs, TUCPs and mRNAs in follicular fluid from healthy women and women with PCOS To elucidate the possible functional significance of the observed changes in lncRNA and TUCP levels between follicular fluids from mature and immature follicles in normal and PCOS ovaries, respectively, GO and KEGG analysis were performed. The differentially expressed lncRNAs were significantly associated with single-organism processes and various developmental processes in every case group (Fig. 3A-D) . In addition, the metabolic process was highly enriched in follicular fluid from mature follicles of PCOS patients relative to fluid from normal mature follicles (Fig. 3B) . Within the healthy patient group, the junction adhesion and communication-related processes were highly enriched in follicular fluid from mature versus immature follicles (Fig. 3A) . Within the PCOS group, the nervous system process was highly enriched in follicular fluids from mature versus immature follicles (Fig. 3C) .
It is noteworthy that the differentially expressed mRNAs were primarily linked to olfactory transduction pathways in every case group (Fig. 3E-H) . In addition, GO and STRING analysis indicated that the biological process term 'plasma membrane proteins', the molecular function term 'olfactory receptor activity', and the cellular component term 'sensory perception of smell' were mainly enriched ( Supplementary Fig. S3Ai-Di) ; and suggested that GNB1, GNAL and GNGT1 were the most important nodes in the olfactory transduction network ( Supplementary Fig. S3Aii-Dii) .
The differentially expressed TUCPs were also significantly associated with various developmental processes in every case group ( Supplementary  Fig. S4A-D) . The single-organism process was significantly enriched in every case group, except for the comparison between mature follicular fluids from PCOS patients and healthy women (Supplementary Fig. S4B ). The junction adhesion and communication-related processes were highly enriched in follicular fluids from mature versus immature follicles in the healthy group, as well as in the PCOS group relative to fluid from immature follicles in the healthy group ( Supplementary Fig. S4A and D) . Nervous system process was highly enriched in follicular fluid from mature follicles in PCOS patients versus normal mature follicles, as well as in mature versus immature subsets within the PCOS group ( Supplementary Fig. S4B and C) . Metabolic process was the most frequent term when comparing fluids from mature and immature follicles within the PCOS group ( Supplementary  Fig. S4C ). No significant enrichment of lncRNAs and TUCPs was observed using KEGG analysis ( Supplementary Fig. S5 and S6) .
To further explore our findings, GSEA was performed using the ranked-ordered gene list. GSEA is predicated on the choice of a predefined collection of sets, but not pre-selected differentially expressed genes. Notably, telomere maintenance, mitogen-activated protein kinase (MAPK) pathway, and Wnt signaling pathway were co-enriched in follicular fluid from mature and immature follicles, regardless of whether follicles were normal or from women with PCOS ( Fig. 4Ai and Aii). The monosaccharide biosynthetic process was co-enriched in normal and PCOS follicles, regardless of whether the follicles were mature or immature (Fig. 4Bi and Bii) . In addition, all overlapping genes in each key pathway were retrieved by leading-edge analysis and visualized with the RCircos package, suggesting that there is a wide range of interactions among these pathway genes ( Fig. 4C and D) .
Identification in follicular fluid of candidate causal genes underlying PCOS phenotypes
We constructed co-expression networks through WGCNA and identified 31 independent transcriptional modules for lncRNAs ( Fig. 5A and B) , and 37 independent transcriptional module for mRNAs ( Fig. 6A and B) and lncRNAs/mRNAs ( Supplementary Fig. S7 ); each transcriptional module was assigned a color.
Using the GS and MM measures as described in the WGCNA method (Langfelder and Horvath, 2008) , we identified the genes that showed a high significance for weight and interesting modules. We then created scatterplots of GS versus MM in selected significant modules ( Supplementary Fig. S8 , correlation >0.6). Transcriptional coexpression of genes might, however, have similar regulatory effects in the same modules. Therefore, based on the results of GS versus MM mentioned above, we identified many potential co-regulatory relationships among lncRNAs, mRNAs and PCOS phenotypes in follicular fluid. For example, (i) RP11-2N1.2, CTC-338M12.6, RP11-547D23.1 and RP11-834C11.4 were most relevant to androstenedione (Fig. 5C); (ii) CTD-2034I21.1, LINC01448, AC005614.5, B4GALT1-AS1 and FLJ33581 were most relevant to LH (Fig. 5D) ; (iii) RP11-510N19.5 and AC019172.2 was most relevant to TSH (Fig. 5E) . In this analysis, we also identified in follicular fluid that (i) PLEKHA2 and DSCC1 were most relevant to DHEAS and estradiol (Fig. 6C); (ii) ZNF346, BMPR1B, and GPR160 were most relevant to androstenedione (Fig. 6D) ; (iii) UNC5B and MYC were most relevant to LH (Fig. 6E) ; and (iv) FAM3C and EIF5 were most relevant to TSH (Fig. 6F) .
After analyzing the co-expression relationships between lncRNAs/ mRNAs and PCOS phenotypes ( Supplementary Fig. S7 ), we used Cytoscape to visualize the network among the most connected lncRNAs and mRNAs in significant modules of co-expressed genes, based on the results of GS versus MM mentioned above (Supplementary Fig. S8 ). The lncRNAs and mRNAs had higher GS, which represented a higher correlation between the gene and the trait (Supplementary Fig. S8 ). Our analysis also provided some causal candidates, some of which were core and relevant to clinical traits in the lncRNA and mRNA interaction network. For example, (i) MYO5A, UNC119 genes and lncRNA RP11-510N19.5 were relevant to TSH & FSH phenotypes (Fig. 7A); (ii) MYC, MRPL24, SNU13, UNC5B and MEF2A genes were relevant to LH phenotypes (Fig. 7B) ; (iii) DDX3X, DNAJA4, PLEKHA2, TSHZ1, C7orf43 genes and lncRNA SDCBP2-AS1 were relevant to estradiol phenotypes (Fig. 7C) ; and (iv) BMPR1B, ATP13A3, LACTB2, ZNF346 and HOXB-AS3 genes were relevant to androstenedione & triglyceride phenotypes (Fig. 7D) .
Collectively, these relationships suggest that diverse molecular pathways are involved in PCOS phenotypes, and that these may be under the control of several key signaling nodes. 
Discussion
In the current study, we used RNA sequencing to provide the first descriptions of lncRNA and mRNA profiles in human follicular fluid samples, and to further confirm the molecular diversity of mature and immature follicles in both normal and PCOS ovaries. In addition, we performed a multi-level analysis to investigate how lncRNA and mRNA networks contribute to PCOS phenotypes.
First, we identified many co-regulatory relationships among lncRNAs, mRNAs, and PCOS phenotypes. For example, hyperandrogenism is a core feature of PCOS (Azziz et al., 2016) , and WGCNA of the coexpression/regulatory networks indicated that 4 lncRNAs (RP11-2N1.2, CTC-338M12.6, RP11-547D23.1, and RP11-834C11.4), and 3 mRNAs (ZNF346, BMPR1B and GPR160) were most relevant to serum androstenedione levels. In addition, BMPR1B and ZNF346 are key driver genes in the androstenedione-related lncRNA-mRNA interactive network. Also, 5 lncRNAs (CTD-2034I21.1, LINC01448, AC005614.5, B4GALT1-AS1 and FLJ33581) and 2 mRNAs (UNC5B and MYC) were most relevant to serum LH levels, and UNC5B and MYC are key driver genes in the LH-related lncRNA-mRNA interactive network. Notably, several of our observations are already well supported by others. For example, BMPs can potentially regulate thecal androgen synthesis (Glister et al., 2010) as LH levels were increased in the Bmyc knockout mouse (Turunen et al., 2012 GSEA-GO enrichment indicated that telomere maintenance and MAPK and Wnt signaling pathways were co-enriched in the follicular fluid from mature and immature follicles, regardless of whether the follicles were normal or from women with PCOS. The monosaccharide biosynthetic process was co-enriched in the follicular fluid from normal and PCOS follicles regardless of whether the follicles were mature or immature. This suggests that telomere maintenance and MAPK and Wnt pathways may be conservative and active processes in follicular development from the early antral to antral and preovulatory stages. Recent research suggests that granulosa cell telomerase activity and telomere length are relevant to PCOS and primary ovarian insufficiency (Li et al., 2017; Xu et al., 2017) , and that MAPK and WNT signaling pathways also play significant physiologic roles in ovarian and follicular development (Abedini et al., 2015; Prasasya and Mayo, 2018) . Although monosaccharide biosynthesis may be a possible pathway marker to distinguish between normal and PCOS follicles, there is currently little known about the role of monosaccharides in the development of both normal and PCOS follicles.
Our integrative analysis also yielded some unexpected results. For instance, the differentially expressed transcripts within human follicular fluid were closely linked to olfactory transduction pathways in every case group. In fact, there are presently no known specific functions of olfactory-related molecules and pathways in the development of follicles, nor are there any known relationships among olfactory system dysfunction, the oocyte maturation environment, or in occurrence of long-term diseases. It is worth noting that although olfactory dysfunction is common, less than 25% of individuals are aware of a dysfunction in their ability to sense odors until they are formally evaluated (Doty, 2017) . Similarly, a recent report indicated that PCOS patients showed significantly impaired olfactory function and depressive disorders (Koseoglu et al., 2016) . Interestingly, olfactory dysfunction is closely related to neurodegenerative diseases (Doty, 2017 whether the olfactory loss precedes the onset of neuropathologic lesions or whether it is simply caused by neuropathology. We also considered whether loss of olfaction may be caused by exposure of the oocyte to a dysfunctional olfactory microenvironment.
Consistent with this hypothesis, the differentially expressed transcripts in our study were significantly associated with nervous system development, neurogenesis, neuron projection morphogenesis, neuron development and differentiation. This information opens new avenues Figure 7 Systematic transcriptome-wide analysis of long non-coding/messenger RNA (lncRNA/mRNA) co-expression in different polycystic ovary syndrome (PCOS) phenotypes. Each node represents a lncRNA or mRNA. Arrows indicate the possible interactive relationships among lncRNAs and mRNAs, lncRNAs and lncRNAs, and mRNAs and mRNAs. The large purple circle indicates the core node of lncRNAs, and the large red circle indicates the core node of mRNAs, the small square indicates the key node of lncRNAs, and the small circle indicates the key node of mRNAs; the color is identical to the mRNA co-expression modules. See Supplementary Fig. S7 for the topological overlap matrix (TOM) and module selection of lncRNA/ mRNA interactions.
toward our understanding of the pathogenesis of neurodegenerative diseases and other metabolic diseases from the aspect of creating an abnormal environment for oocyte maturation. Overall, the results of this study showed for the first time the differences between lncRNA and mRNA profiles in the follicular fluid of mature and immature follicles from healthy women and PCOS patients. Moreover, molecular interaction networks were linked to the diverse PCOS phenotypes. It remains unclear, however, whether these differential transcripts contribute directly to follicular development and pathogenesis of PCOS or are merely biomarkers. Nevertheless, these molecular indices will be important for future investigations of the biologic mechanisms underlying follicle development in both healthy women and in women with PCOS.
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